Trials / Recruiting
RecruitingNCT07413666
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
A Safety, Tolerability, Pharmacokinetic, Food Effect, and Proof-of-Concept Study of Single and Multiple Doses of ORX489 in Healthy Adults
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 212 (estimated)
- Sponsor
- Centessa Pharmaceuticals (UK) Limited · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ORX489 Tablets | ORX489 Tablets |
| OTHER | Placebo Tablets | Placebo Tablets |
Timeline
- Start date
- 2026-02-25
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2026-02-17
- Last updated
- 2026-02-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07413666. Inclusion in this directory is not an endorsement.